A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.
This report aims to provide a comprehensive presentation of the global market for Human Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Vaccine. This report contains market size and forecasts of Human Vaccine in global, including the following market information:
Global Human Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Human Vaccine Market Sales, 2018-2023, 2024-2029, (M Doses)
Global top five Human Vaccine companies in 2022 (%)
The global Human Vaccine market was valued at US$ 32870 million in 2022 and is projected to reach US$ 44570 million by 2029, at a CAGR of 4.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In China, Human Vaccine key players include CNBG, Kangtai, ChengDa Bio, etc. Global top three manufacturers hold a share about 65%.
East China is the largest market, with a share about 25%, followed by South China, and North China, both have a share about 40 percent.
In terms of product, Hepatitis B is the largest segment, with a share nearly 15%. And in terms of application, the largest application is Children, followed by Adults.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Human Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Human Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (M Doses)
Global Human Vaccine Market Segment Percentages, by Type, 2022 (%)
- Varicella
- Influenza
- Polio
- Hepatitis A
- Rabies
- BCG
- Hepatitis B
- Pertussis, Diphtheria, Tetanus
- Pneumococcal
- Rota vaccine
Global Human Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (M Doses)
Global Human Vaccine Market Segment Percentages, by Application, 2022 (%)
- Adults
- Children
Global Human Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (M Doses)
Global Human Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- - US
- - Canada
- - Mexico
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- - Nordic Countries
- - Benelux
- - Rest of Europe
- Asia
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Rest of Asia
- South America
- - Brazil
- - Argentina
- - Rest of South America
- Middle East & Africa
- - Turkey
- - Israel
- - Saudi Arabia
- - UAE
- - Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Human Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Human Vaccine revenues share in global market, 2022 (%)
Key companies Human Vaccine sales in global market, 2018-2023 (Estimated), (M Doses)
Key companies Human Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- CNBG
- Changsheng Life
- Zhifei
- ChengDa Bio
- Kangtai
- SINOVAC BIOTECH
- Hissen
- Walvax Biotechnology
- GSK
- SANOFI
- Rong An
- NuoCheng Bio
- Hualan Bio
- Tiantan biological
- Changchun Baike
- Adimmune
- Zhongyianke Biotech
- Bharat Biotech
- Bavarian Nordic
- Sanofi-Pasteur
- Indian Immunologicals
- KANGH
- Henan Grand Biopharma
- ZhongKe Biopharm
- Zhuoyi Biological
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Vaccine, market overview.
Chapter 2: Global Human Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Human Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Human Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
Human Vaccine Market, Global Outlook and Forecast 2023-2029
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Human Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Vaccine Overall Market Size
2.1 Global Human Vaccine Market Size: 2022 VS 2029
2.2 Global Human Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Human Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Human Vaccine Players in Global Market
3.2 Top Global Human Vaccine Companies Ranked by Revenue
3.3 Global Human Vaccine Revenue by Companies
3.4 Global Human Vaccine Sales by Companies
3.5 Global Human Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Human Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Human Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Human Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Human Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Human Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Human Vaccine Market Size Markets, 2022 & 2029
4.1.2 Varicella
4.1.3 Influenza
4.1.4 Polio
4.1.5 Hepatitis A
4.1.6 Rabies
4.1.7 BCG
4.1.8 Hepatitis B
4.1.9 Pertussis, Diphtheria, Tetanus
4.1.10 Pneumococcal
4.1.11 Rota vaccine
4.2 By Type - Global Human Vaccine Revenue & Forecasts
4.2.1 By Type - Global Human Vaccine Revenue, 2018-2023
4.2.2 By Type - Global Human Vaccine Revenue, 2024-2029
4.2.3 By Type - Global Human Vaccine Revenue Market Share, 2018-2029
4.3 By Type - Global Human Vaccine Sales & Forecasts
4.3.1 By Type - Global Human Vaccine Sales, 2018-2023
4.3.2 By Type - Global Human Vaccine Sales, 2024-2029
4.3.3 By Type - Global Human Vaccine Sales Market Share, 2018-2029
4.4 By Type - Global Human Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Human Vaccine Market Size, 2022 & 2029
5.1.2 Adults
5.1.3 Children
5.2 By Application - Global Human Vaccine Revenue & Forecasts
5.2.1 By Application - Global Human Vaccine Revenue, 2018-2023
5.2.2 By Application - Global Human Vaccine Revenue, 2024-2029
5.2.3 By Application - Global Human Vaccine Revenue Market Share, 2018-2029
5.3 By Application - Global Human Vaccine Sales & Forecasts
5.3.1 By Application - Global Human Vaccine Sales, 2018-2023
5.3.2 By Application - Global Human Vaccine Sales, 2024-2029
5.3.3 By Application - Global Human Vaccine Sales Market Share, 2018-2029
5.4 By Application - Global Human Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Human Vaccine Market Size, 2022 & 2029
6.2 By Region - Global Human Vaccine Revenue & Forecasts
6.2.1 By Region - Global Human Vaccine Revenue, 2018-2023
6.2.2 By Region - Global Human Vaccine Revenue, 2024-2029
6.2.3 By Region - Global Human Vaccine Revenue Market Share, 2018-2029
6.3 By Region - Global Human Vaccine Sales & Forecasts
6.3.1 By Region - Global Human Vaccine Sales, 2018-2023
6.3.2 By Region - Global Human Vaccine Sales, 2024-2029
6.3.3 By Region - Global Human Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Human Vaccine Revenue, 2018-2029
6.4.2 By Country - North America Human Vaccine Sales, 2018-2029
6.4.3 US Human Vaccine Market Size, 2018-2029
6.4.4 Canada Human Vaccine Market Size, 2018-2029
6.4.5 Mexico Human Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Human Vaccine Revenue, 2018-2029
6.5.2 By Country - Europe Human Vaccine Sales, 2018-2029
6.5.3 Germany Human Vaccine Market Size, 2018-2029
6.5.4 France Human Vaccine Market Size, 2018-2029
6.5.5 U.K. Human Vaccine Market Size, 2018-2029
6.5.6 Italy Human Vaccine Market Size, 2018-2029
6.5.7 Russia Human Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Human Vaccine Market Size, 2018-2029
6.5.9 Benelux Human Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Human Vaccine Revenue, 2018-2029
6.6.2 By Region - Asia Human Vaccine Sales, 2018-2029
6.6.3 China Human Vaccine Market Size, 2018-2029
6.6.4 Japan Human Vaccine Market Size, 2018-2029
6.6.5 South Korea Human Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Human Vaccine Market Size, 2018-2029
6.6.7 India Human Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Human Vaccine Revenue, 2018-2029
6.7.2 By Country - South America Human Vaccine Sales, 2018-2029
6.7.3 Brazil Human Vaccine Market Size, 2018-2029
6.7.4 Argentina Human Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Human Vaccine Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Human Vaccine Sales, 2018-2029
6.8.3 Turkey Human Vaccine Market Size, 2018-2029
6.8.4 Israel Human Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Human Vaccine Market Size, 2018-2029
6.8.6 UAE Human Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 CNBG
7.1.1 CNBG Company Summary
7.1.2 CNBG Business Overview
7.1.3 CNBG Human Vaccine Major Product Offerings
7.1.4 CNBG Human Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 CNBG Key News & Latest Developments
7.2 Changsheng Life
7.2.1 Changsheng Life Company Summary
7.2.2 Changsheng Life Business Overview
7.2.3 Changsheng Life Human Vaccine Major Product Offerings
7.2.4 Changsheng Life Human Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Changsheng Life Key News & Latest Developments
7.3 Zhifei
7.3.1 Zhifei Company Summary
7.3.2 Zhifei Business Overview
7.3.3 Zhifei Human Vaccine Major Product Offerings
7.3.4 Zhifei Human Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Zhifei Key News & Latest Developments
7.4 ChengDa Bio
7.4.1 ChengDa Bio Company Summary
7.4.2 ChengDa Bio Business Overview
7.4.3 ChengDa Bio Human Vaccine Major Product Offerings
7.4.4 ChengDa Bio Human Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 ChengDa Bio Key News & Latest Developments
7.5 Kangtai
7.5.1 Kangtai Company Summary
7.5.2 Kangtai Business Overview
7.5.3 Kangtai Human Vaccine Major Product Offerings
7.5.4 Kangtai Human Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 Kangtai Key News & Latest Developments
7.6 SINOVAC BIOTECH
7.6.1 SINOVAC BIOTECH Company Summary
7.6.2 SINOVAC BIOTECH Business Overview
7.6.3 SINOVAC BIOTECH Human Vaccine Major Product Offerings
7.6.4 SINOVAC BIOTECH Human Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 SINOVAC BIOTECH Key News & Latest Developments
7.7 Hissen
7.7.1 Hissen Company Summary
7.7.2 Hissen Business Overview
7.7.3 Hissen Human Vaccine Major Product Offerings
7.7.4 Hissen Human Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 Hissen Key News & Latest Developments
7.8 Walvax Biotechnology
7.8.1 Walvax Biotechnology Company Summary
7.8.2 Walvax Biotechnology Business Overview
7.8.3 Walvax Biotechnology Human Vaccine Major Product Offerings
7.8.4 Walvax Biotechnology Human Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 Walvax Biotechnology Key News & Latest Developments
7.9 GSK
7.9.1 GSK Company Summary
7.9.2 GSK Business Overview
7.9.3 GSK Human Vaccine Major Product Offerings
7.9.4 GSK Human Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 GSK Key News & Latest Developments
7.10 SANOFI
7.10.1 SANOFI Company Summary
7.10.2 SANOFI Business Overview
7.10.3 SANOFI Human Vaccine Major Product Offerings
7.10.4 SANOFI Human Vaccine Sales and Revenue in Global (2018-2023)
7.10.5 SANOFI Key News & Latest Developments
7.11 Rong An
7.11.1 Rong An Company Summary
7.11.2 Rong An Human Vaccine Business Overview
7.11.3 Rong An Human Vaccine Major Product Offerings
7.11.4 Rong An Human Vaccine Sales and Revenue in Global (2018-2023)
7.11.5 Rong An Key News & Latest Developments
7.12 NuoCheng Bio
7.12.1 NuoCheng Bio Company Summary
7.12.2 NuoCheng Bio Human Vaccine Business Overview
7.12.3 NuoCheng Bio Human Vaccine Major Product Offerings
7.12.4 NuoCheng Bio Human Vaccine Sales and Revenue in Global (2018-2023)
7.12.5 NuoCheng Bio Key News & Latest Developments
7.13 Hualan Bio
7.13.1 Hualan Bio Company Summary
7.13.2 Hualan Bio Human Vaccine Business Overview
7.13.3 Hualan Bio Human Vaccine Major Product Offerings
7.13.4 Hualan Bio Human Vaccine Sales and Revenue in Global (2018-2023)
7.13.5 Hualan Bio Key News & Latest Developments
7.14 Tiantan biological
7.14.1 Tiantan biological Company Summary
7.14.2 Tiantan biological Business Overview
7.14.3 Tiantan biological Human Vaccine Major Product Offerings
7.14.4 Tiantan biological Human Vaccine Sales and Revenue in Global (2018-2023)
7.14.5 Tiantan biological Key News & Latest Developments
7.15 Changchun Baike
7.15.1 Changchun Baike Company Summary
7.15.2 Changchun Baike Business Overview
7.15.3 Changchun Baike Human Vaccine Major Product Offerings
7.15.4 Changchun Baike Human Vaccine Sales and Revenue in Global (2018-2023)
7.15.5 Changchun Baike Key News & Latest Developments
7.16 Adimmune
7.16.1 Adimmune Company Summary
7.16.2 Adimmune Business Overview
7.16.3 Adimmune Human Vaccine Major Product Offerings
7.16.4 Adimmune Human Vaccine Sales and Revenue in Global (2018-2023)
7.16.5 Adimmune Key News & Latest Developments
7.17 Zhongyianke Biotech
7.17.1 Zhongyianke Biotech Company Summary
7.17.2 Zhongyianke Biotech Business Overview
7.17.3 Zhongyianke Biotech Human Vaccine Major Product Offerings
7.17.4 Zhongyianke Biotech Human Vaccine Sales and Revenue in Global (2018-2023)
7.17.5 Zhongyianke Biotech Key News & Latest Developments
7.18 Bharat Biotech
7.18.1 Bharat Biotech Company Summary
7.18.2 Bharat Biotech Business Overview
7.18.3 Bharat Biotech Human Vaccine Major Product Offerings
7.18.4 Bharat Biotech Human Vaccine Sales and Revenue in Global (2018-2023)
7.18.5 Bharat Biotech Key News & Latest Developments
7.19 Bavarian Nordic
7.19.1 Bavarian Nordic Company Summary
7.19.2 Bavarian Nordic Business Overview
7.19.3 Bavarian Nordic Human Vaccine Major Product Offerings
7.19.4 Bavarian Nordic Human Vaccine Sales and Revenue in Global (2018-2023)
7.19.5 Bavarian Nordic Key News & Latest Developments
7.20 Sanofi-Pasteur
7.20.1 Sanofi-Pasteur Company Summary
7.20.2 Sanofi-Pasteur Business Overview
7.20.3 Sanofi-Pasteur Human Vaccine Major Product Offerings
7.20.4 Sanofi-Pasteur Human Vaccine Sales and Revenue in Global (2018-2023)
7.20.5 Sanofi-Pasteur Key News & Latest Developments
7.21 Indian Immunologicals
7.21.1 Indian Immunologicals Company Summary
7.21.2 Indian Immunologicals Business Overview
7.21.3 Indian Immunologicals Human Vaccine Major Product Offerings
7.21.4 Indian Immunologicals Human Vaccine Sales and Revenue in Global (2018-2023)
7.21.5 Indian Immunologicals Key News & Latest Developments
7.22 KANGH
7.22.1 KANGH Company Summary
7.22.2 KANGH Business Overview
7.22.3 KANGH Human Vaccine Major Product Offerings
7.22.4 KANGH Human Vaccine Sales and Revenue in Global (2018-2023)
7.22.5 KANGH Key News & Latest Developments
7.23 Henan Grand Biopharma
7.23.1 Henan Grand Biopharma Company Summary
7.23.2 Henan Grand Biopharma Business Overview
7.23.3 Henan Grand Biopharma Human Vaccine Major Product Offerings
7.23.4 Henan Grand Biopharma Human Vaccine Sales and Revenue in Global (2018-2023)
7.23.5 Henan Grand Biopharma Key News & Latest Developments
7.24 ZhongKe Biopharm
7.24.1 ZhongKe Biopharm Company Summary
7.24.2 ZhongKe Biopharm Business Overview
7.24.3 ZhongKe Biopharm Human Vaccine Major Product Offerings
7.24.4 ZhongKe Biopharm Human Vaccine Sales and Revenue in Global (2018-2023)
7.24.5 ZhongKe Biopharm Key News & Latest Developments
7.25 Zhuoyi Biological
7.25.1 Zhuoyi Biological Company Summary
7.25.2 Zhuoyi Biological Business Overview
7.25.3 Zhuoyi Biological Human Vaccine Major Product Offerings
7.25.4 Zhuoyi Biological Human Vaccine Sales and Revenue in Global (2018-2023)
7.25.5 Zhuoyi Biological Key News & Latest Developments
8 Global Human Vaccine Production Capacity, Analysis
8.1 Global Human Vaccine Production Capacity, 2018-2029
8.2 Human Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Human Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Human Vaccine Supply Chain Analysis
10.1 Human Vaccine Industry Value Chain
10.2 Human Vaccine Upstream Market
10.3 Human Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Human Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Human Vaccine in Global Market
Table 2. Top Human Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Human Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Human Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Human Vaccine Sales by Companies, (M Doses), 2018-2023
Table 6. Global Human Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Human Vaccine Price (2018-2023) & (USD/Dose)
Table 8. Global Manufacturers Human Vaccine Product Type
Table 9. List of Global Tier 1 Human Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type - Global Human Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Human Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Human Vaccine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Human Vaccine Sales (M Doses), 2018-2023
Table 15. By Type - Global Human Vaccine Sales (M Doses), 2024-2029
Table 16. By Application - Global Human Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Human Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Human Vaccine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Human Vaccine Sales (M Doses), 2018-2023
Table 20. By Application - Global Human Vaccine Sales (M Doses), 2024-2029
Table 21. By Region - Global Human Vaccine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Human Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Human Vaccine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Human Vaccine Sales (M Doses), 2018-2023
Table 25. By Region - Global Human Vaccine Sales (M Doses), 2024-2029
Table 26. By Country - North America Human Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Human Vaccine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Human Vaccine Sales, (M Doses), 2018-2023
Table 29. By Country - North America Human Vaccine Sales, (M Doses), 2024-2029
Table 30. By Country - Europe Human Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Human Vaccine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Human Vaccine Sales, (M Doses), 2018-2023
Table 33. By Country - Europe Human Vaccine Sales, (M Doses), 2024-2029
Table 34. By Region - Asia Human Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Human Vaccine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Human Vaccine Sales, (M Doses), 2018-2023
Table 37. By Region - Asia Human Vaccine Sales, (M Doses), 2024-2029
Table 38. By Country - South America Human Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Human Vaccine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Human Vaccine Sales, (M Doses), 2018-2023
Table 41. By Country - South America Human Vaccine Sales, (M Doses), 2024-2029
Table 42. By Country - Middle East & Africa Human Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Human Vaccine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Human Vaccine Sales, (M Doses), 2018-2023
Table 45. By Country - Middle East & Africa Human Vaccine Sales, (M Doses), 2024-2029
Table 46. CNBG Company Summary
Table 47. CNBG Human Vaccine Product Offerings
Table 48. CNBG Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 49. CNBG Key News & Latest Developments
Table 50. Changsheng Life Company Summary
Table 51. Changsheng Life Human Vaccine Product Offerings
Table 52. Changsheng Life Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 53. Changsheng Life Key News & Latest Developments
Table 54. Zhifei Company Summary
Table 55. Zhifei Human Vaccine Product Offerings
Table 56. Zhifei Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 57. Zhifei Key News & Latest Developments
Table 58. ChengDa Bio Company Summary
Table 59. ChengDa Bio Human Vaccine Product Offerings
Table 60. ChengDa Bio Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 61. ChengDa Bio Key News & Latest Developments
Table 62. Kangtai Company Summary
Table 63. Kangtai Human Vaccine Product Offerings
Table 64. Kangtai Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 65. Kangtai Key News & Latest Developments
Table 66. SINOVAC BIOTECH Company Summary
Table 67. SINOVAC BIOTECH Human Vaccine Product Offerings
Table 68. SINOVAC BIOTECH Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 69. SINOVAC BIOTECH Key News & Latest Developments
Table 70. Hissen Company Summary
Table 71. Hissen Human Vaccine Product Offerings
Table 72. Hissen Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 73. Hissen Key News & Latest Developments
Table 74. Walvax Biotechnology Company Summary
Table 75. Walvax Biotechnology Human Vaccine Product Offerings
Table 76. Walvax Biotechnology Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 77. Walvax Biotechnology Key News & Latest Developments
Table 78. GSK Company Summary
Table 79. GSK Human Vaccine Product Offerings
Table 80. GSK Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 81. GSK Key News & Latest Developments
Table 82. SANOFI Company Summary
Table 83. SANOFI Human Vaccine Product Offerings
Table 84. SANOFI Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 85. SANOFI Key News & Latest Developments
Table 86. Rong An Company Summary
Table 87. Rong An Human Vaccine Product Offerings
Table 88. Rong An Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 89. Rong An Key News & Latest Developments
Table 90. NuoCheng Bio Company Summary
Table 91. NuoCheng Bio Human Vaccine Product Offerings
Table 92. NuoCheng Bio Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 93. NuoCheng Bio Key News & Latest Developments
Table 94. Hualan Bio Company Summary
Table 95. Hualan Bio Human Vaccine Product Offerings
Table 96. Hualan Bio Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 97. Hualan Bio Key News & Latest Developments
Table 98. Tiantan biological Company Summary
Table 99. Tiantan biological Human Vaccine Product Offerings
Table 100. Tiantan biological Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 101. Tiantan biological Key News & Latest Developments
Table 102. Changchun Baike Company Summary
Table 103. Changchun Baike Human Vaccine Product Offerings
Table 104. Changchun Baike Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 105. Changchun Baike Key News & Latest Developments
Table 106. Adimmune Company Summary
Table 107. Adimmune Human Vaccine Product Offerings
Table 108. Adimmune Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 109. Adimmune Key News & Latest Developments
Table 110. Zhongyianke Biotech Company Summary
Table 111. Zhongyianke Biotech Human Vaccine Product Offerings
Table 112. Zhongyianke Biotech Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 113. Zhongyianke Biotech Key News & Latest Developments
Table 114. Bharat Biotech Company Summary
Table 115. Bharat Biotech Human Vaccine Product Offerings
Table 116. Bharat Biotech Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 117. Bharat Biotech Key News & Latest Developments
Table 118. Bavarian Nordic Company Summary
Table 119. Bavarian Nordic Human Vaccine Product Offerings
Table 120. Bavarian Nordic Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 121. Bavarian Nordic Key News & Latest Developments
Table 122. Sanofi-Pasteur Company Summary
Table 123. Sanofi-Pasteur Human Vaccine Product Offerings
Table 124. Sanofi-Pasteur Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 125. Sanofi-Pasteur Key News & Latest Developments
Table 126. Indian Immunologicals Company Summary
Table 127. Indian Immunologicals Human Vaccine Product Offerings
Table 128. Indian Immunologicals Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 129. Indian Immunologicals Key News & Latest Developments
Table 130. KANGH Company Summary
Table 131. KANGH Human Vaccine Product Offerings
Table 132. KANGH Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 133. KANGH Key News & Latest Developments
Table 134. Henan Grand Biopharma Company Summary
Table 135. Henan Grand Biopharma Human Vaccine Product Offerings
Table 136. Henan Grand Biopharma Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 137. Henan Grand Biopharma Key News & Latest Developments
Table 138. ZhongKe Biopharm Company Summary
Table 139. ZhongKe Biopharm Human Vaccine Product Offerings
Table 140. ZhongKe Biopharm Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 141. ZhongKe Biopharm Key News & Latest Developments
Table 142. Zhuoyi Biological Company Summary
Table 143. Zhuoyi Biological Human Vaccine Product Offerings
Table 144. Zhuoyi Biological Human Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 145. Zhuoyi Biological Key News & Latest Developments
Table 146. Human Vaccine Production Capacity (M Doses) of Key Manufacturers in Global Market, 2021-2023 (M Doses)
Table 147. Global Human Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 148. Global Human Vaccine Production by Region, 2018-2023 (M Doses)
Table 149. Global Human Vaccine Production by Region, 2024-2029 (M Doses)
Table 150. Human Vaccine Market Opportunities & Trends in Global Market
Table 151. Human Vaccine Market Drivers in Global Market
Table 152. Human Vaccine Market Restraints in Global Market
Table 153. Human Vaccine Raw Materials
Table 154. Human Vaccine Raw Materials Suppliers in Global Market
Table 155. Typical Human Vaccine Downstream
Table 156. Human Vaccine Downstream Clients in Global Market
Table 157. Human Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Human Vaccine Segment by Type in 2022
Figure 2. Human Vaccine Segment by Application in 2022
Figure 3. Global Human Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Human Vaccine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Human Vaccine Revenue, 2018-2029 (US$, Mn)
Figure 7. Human Vaccine Sales in Global Market: 2018-2029 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Human Vaccine Revenue in 2022
Figure 9. By Type - Global Human Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Human Vaccine Revenue Market Share, 2018-2029
Figure 11. By Type - Global Human Vaccine Sales Market Share, 2018-2029
Figure 12. By Type - Global Human Vaccine Price (USD/Dose), 2018-2029
Figure 13. By Application - Global Human Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Human Vaccine Revenue Market Share, 2018-2029
Figure 15. By Application - Global Human Vaccine Sales Market Share, 2018-2029
Figure 16. By Application - Global Human Vaccine Price (USD/Dose), 2018-2029
Figure 17. By Region - Global Human Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Human Vaccine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Human Vaccine Revenue Market Share, 2018-2029
Figure 20. By Region - Global Human Vaccine Sales Market Share, 2018-2029
Figure 21. By Country - North America Human Vaccine Revenue Market Share, 2018-2029
Figure 22. By Country - North America Human Vaccine Sales Market Share, 2018-2029
Figure 23. US Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Human Vaccine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Human Vaccine Sales Market Share, 2018-2029
Figure 28. Germany Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 29. France Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Human Vaccine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Human Vaccine Sales Market Share, 2018-2029
Figure 37. China Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 41. India Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Human Vaccine Revenue Market Share, 2018-2029
Figure 43. By Country - South America Human Vaccine Sales Market Share, 2018-2029
Figure 44. Brazil Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Human Vaccine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Human Vaccine Sales Market Share, 2018-2029
Figure 48. Turkey Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Human Vaccine Revenue, (US$, Mn), 2018-2029
Figure 52. Global Human Vaccine Production Capacity (M Doses), 2018-2029
Figure 53. The Percentage of Production Human Vaccine by Region, 2022 VS 2029
Figure 54. Human Vaccine Industry Value Chain
Figure 55. Marketing Channels
Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 87
The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030.
North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
Global Esomeprazole Magnesium Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 74
The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030.
North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
Global Combination Therapy Drug Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
Global Axitinib Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 68
The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
Global Lyme Disease Vaccine Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 70
The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi.
The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at......
Global Transdermal Absorption Patch Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 85
The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
Global Ketoprofen Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 78
Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis
The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
Global Methyl Salicylate Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 82
The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
Global Diclofenac Patches Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 94
The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
